Revolutionizing Disease Prevention with Smarter, Personalized Care

AI-Driven Precision Medicine for Clinicians

Our Mission

We are on a mission to improve health outcomes. Our solutions help prevent disease and save lives.

Our Story

Today, preventive care is limited by the lack of genomic data in clinical workflows, making early intervention difficult and reducing patient engagement.

OpenDNA bridges this gap by integrating AI-powered genetic and clinical data into everyday practice. Our platform makes risk clear, actionable, and personal – empowering clinicians and patients to improve health outcomes and quality of life.

“Our groundbreaking AI technology is disrupting preventive medicine. It saves lives, improves quality of life, and significantly reduces healthcare costs worldwide!”

Dr. Eran Feldhay
CEO, OpenDNA

Leadership Team

OpenDNA is led by experts in genomics, artificial intelligence, and clinical medicine, dedicated to transforming how disease risk is assessed and managed.

Eran Feldhay, CEO

Over 20 years of experience in medical software and devices. Former CEO of ApiFix, CEO of Trendlines Medical, and GM at McKesson Israel.

Erez Ornan, CTO

25 years of experience in software development, previously a software group leader at Bio-Rad.

Nir Gamliel, CBO

Decades of entrepreneurship and international business development experience in Fortune 500 companies and startups. Former CEO of PharBeyond, VP BD at BioLineRx, and VP of Sales at Compugen USA.

Dalia Mor, CFO

25 years of specialized experience in early-stage startups, including financial management, budgeting, investments, legal support, and working with the Israel Innovation Authority.

Evangelos Evangelou, Former CSO

Associate Professor of Clinical and Molecular Epidemiology, Imperial College London & University of Ioannina, GR. With over 220 publications and 30,000 citations, he is recognized among the top 2% of scientists worldwide.

Max Blankfeld, Strategy

Held top management positions in publicly traded companies, founded and sold multiple businesses. Co-founder and COO of Gene by Gene, Board Member at MyDNA, and an investor in several genomic ventures.

Dan Shwarzman, Board Member

A seasoned global healthcare leader, Mr. Shwarzman brings over 15 years of experience spanning Fortune 500 companies and innovative startups, driving growth and advancing medical solutions worldwide.

Arnold Pallay MD, Medical Director

Primary Care Physician. Nationally recognized health care leader. Medical Genetics. Changebridge Medical Associates, Consensus Health.

Advisory Board

Our advisory board consists of leading physicians, researchers, and healthcare executives who guide OpenDNA in advancing precision medicine.

Michael Chen, MD, FACC, FSCAI, RPVI

Highly recognized and awarded U.S. interventional cardiologist at Adventist HealthCare Cardiac Associates, with extensive publications in leading peer-reviewed journals.

Jerome S. Fischer, MD

Board Certified Endocrinologist, Thomas Jefferson University, Advisory Board Glooko.

Prof. Gil Chernin, MD

Head of the Nephrology and Hypertension Institute, Kaplan Medical Center. Past President, The Israeli Society of Nephrology and Hypertension.